SCHEMBL15925239

SCHEMBL15925239

CSc1cc(CCc2ccnc3[nH]c(=O)cnc23)ccc1NC(=O)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932671 0.83 BRAF (1.00) BRAF
SCHEMBL15925278 0.76 BRAF (0.69) BRAF
SCHEMBL3058233 0.75 BRAF (1.00) BRAF
SCHEMBL3754492 0.73 BRAF (1.00) BRAF
SCHEMBL2931091 0.72 BRAF (1.00) BRAF
SCHEMBL9909711 0.72 BRAF (0.76) BRAF
SCHEMBL2976693 0.72 BRAF (1.00) BRAF
SCHEMBL4476197 0.72 BRAF (1.00) BRAF
SCHEMBL9909785 0.70 BRAF (0.66) BRAF
SCHEMBL15925246 0.70 BRAF (0.54) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229391-B1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE CANCER REC TECH LTD (GB) 2014-08-06 EP disclosed